4822 Stories, most recent news story added 1 hour 18 minutes ago
The Food and Drug Administration said Friday it cleared Novartis' seasonal flu vaccine Agriflu for sale. Agriflu is given as a single shot, and is approved for seasonal flu subtypes A and B in people age 18 and older.
Another option to prevent illnesses caused by subtypes A and B influenza virus SILVER SPRING, Md., Nov. 27 /PRNewswire-USNewswire/ -- The U.S.
South San Francisco-based Theravance Inc. and Astellas Pharma Inc. failed to win approval from U.S. regulators to expand the use of their antibiotic, telavancin, to treat pneumonia acquired by hospitalized patients.
Like most executives at companies that deal in health care, Dave Schlotterbeck will keep a close watch on how U.S. lawmakers proceed with health care reform.
(AP:NEW YORK) The Food and Drug Administration said Friday it cleared Novartis' seasonal flu vaccine Agriflu for sale. Agriflu is given as a single shot, and is approved for seasonal flu subtypes A and B in people age 18 and older.
SEATTLE — You might say that E. coli has been very, very good to William Marler. Ditto for salmonella, listeria, hepatitis and the like. If there's an outbreak of food-borne illness anywhere in the country — spinach, cookie dough, hamburgers, you...
The Food and Drug Administration approved a new Novartis AG (NVS, NOVN.VX) flu vaccine, Agriflu, in an accelerated process Friday. The vaccine to prevent disease caused by influenza virus subtypes A and B is for people age 18 and older. It does not prevent the H1N1 virus, also known as swine flu.
A flu warning from the FDA
Researchers have developed technology that turns flat medical scans into vibrant 3-D images that can be shifted, adjusted, zoomed and replayed at will.
(AP:SOUTH SAN FRANCISCO, Calif.) Theravance Inc. said Friday the Food and Drug Administration delayed a decision on whether to approve its infection drug Vitabiv as a treatment for hospital-acquired pneumonia.
Published: Friday, November 27, 2009 at 5:16 a.m. Last Modified: Friday, November 27, 2009 at 5:16 a.m. One was a middle-aged man who refused to get into the shower. The other was a teenager who was afraid to get out.
SOUTH SAN FRANCISCO, CA--(Marketwire - November 27, 2009) - Theravance, Inc. ( NASDAQ : THRX ) announced today that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) related to the telavancin New Drug Application (NDA) for the treatment of nosocomial pneumonia (NP). Telavancin is a bactericidal, once-daily injectable investigational antibiotic for the ...
BOISE, Idaho - Idahoans want a recipe for food safety from the federal government.
Amylin and Eli Lilly have announced that the U.S. Food and Drug Administration has implemented label changes for Byetta which is indicated for the treatment of type II diabetes.
Here's a strange twist: you can find a child safety cap on a bottle of Listerine mouthwash, but not on Lysol, Pine Sol or Mr. Clean.Go figure.
("Teva Files 2nd Citizen's Petition To Block Generic Copaxone" published at 3: 44 p.m. EST Wednesday misstated the year when a generic Copaxone could enter the market in the 10th paragraph. The correct version follows.)
